CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma-Reference-Cited by-同舟云学术

CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma

Published:2016-03 Issue:1 Volume:2 Page:28-35
ISSN:2352-1775
Container-title:Journal of Cellular Immunotherapy
language:en
Short-container-title:Journal of Cellular Immunotherapy

Author:

Guo Bo,Chen Meixia,Han Qingwang,Hui Fan,Dai Hanren,Zhang Wenying,Zhang Yajing,Wang Yao,Zhu Hongli,Han Weidong

Funder

the National Natural Science Foundation of China

the National Basic Science and Development Programme of China

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference29 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study;Kumar;Leukemia,2012

3. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1;Wijdenes;Br J Haematol,1996

4. The phenotype of normal, reactive and malignant plasma cells. Identification of “many and multiple myelomas” and of new targets for myeloma therapy;Bataille;Haematologica,2006

5. Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secret ion and induction of apoptosis in cytogenetically defined subgroups;Bisping;Blood,2006

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond BCMA: newer immune targets in myeloma;Blood Advances;2024-08-16

2. Infections associated with CAR‐T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies;Cancer Medicine;2024-06

3. CAR-T Therapy in Multiple Myeloma: Looking Beyond;Hemato;2024-05-31

4. BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma;Journal of Nanobiotechnology;2024-05-23

5. Current progress of CAR-T-cell therapy for patients with multiple myeloma;International Journal of Hematology;2024-05-23